Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts

Eur J Oral Sci. 2002 Aug;110(4):302-6. doi: 10.1034/j.1600-0722.2002.21247.x.

Abstract

Periodontitis is associated with enhanced production of cytokines, prostaglandins and matrix metalloproteinases (MMPs). The aim of this study was to investigate the production and regulation of MMP-1 and MMP-3 in human gingival fibroblasts challenged with the cytokines interleukin-lbeta (IL-1beta), tumor necrosis factor alpha (TNFalpha) or epidermal growth factor (EGF). The results showed that gingival fibroblasts constitutively produce MMP-1 and MMP-3, and that the cytokines IL-1beta, TNFalpha and EGF increase both MMP-1 and MMP-3 production in gingival fibroblasts. The upregulation by the cytokines was apparent at 8 h of incubation and increased thereafter continuously during 48 h of incubation. The upregulation of MMPs, induced by IL-1beta or TNFalpha, was reduced by the cyxlooxygenase-2 (COX-2) inhibitor NS-398, the p38 MAP-kinase inhibitor SB 203580, and the tyrosine kinase inhibitor herbimycin A. In addition, MMP-1 and MMP-3 production, induced by IL-1beta, TNFalpha or EGF, was strongly reduced by the presence of the glucocorticoid dexamethasone. Our findings demonstrate that the cytokines IL-1beta, TNFalpha and EGF, respectively, enhance both MMP-1 and MMP-3 production in human gingival fibroblasts, and that the signal pathways COX-2, MAP-kinases and tyrosine kinases are partly involved in the production of MMPs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Cyclooxygenase 2
  • Dexamethasone / pharmacology
  • Epidermal Growth Factor / pharmacology
  • Fibroblasts / enzymology
  • Gingiva / cytology
  • Gingiva / enzymology*
  • Humans
  • Inflammation Mediators / pharmacology*
  • Inflammation Mediators / physiology
  • Interleukin-1 / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • MAP Kinase Signaling System
  • Matrix Metalloproteinase 1 / biosynthesis*
  • Matrix Metalloproteinase 3 / biosynthesis*
  • Matrix Metalloproteinase Inhibitors
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Signal Transduction*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Inflammation Mediators
  • Interleukin-1
  • Isoenzymes
  • Matrix Metalloproteinase Inhibitors
  • Membrane Proteins
  • Tumor Necrosis Factor-alpha
  • Epidermal Growth Factor
  • Dexamethasone
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Protein-Tyrosine Kinases
  • Matrix Metalloproteinase 3
  • Matrix Metalloproteinase 1